| Stuck Between Two Stools
Even with today's rapid application software development cycles, large projects are often barely complete before their tools and target platforms are supplanted by newer versions. It's almost as if the pace of tool and platform development is running ahead of the rate at which some application software developers can absorb and make use of them. Competitive Advantage Many ASP.NET (1.0) projects rolled out well after ASP.NET 2.0 had shipped. More than a few new projects are still being developed, even today, with Visual Studio 2003 for .NET 1.1 rather than with VS2005 for .NET 2.0 (let alone 3.0). A few continue to use even earlier versions of Microsoft tools and platforms. This may save a bit of money in the short term by avoiding the costs to upgrade tools and platforms.
Mylan Labs among Wall Street's movers
Fiscal third-quarter profits for the producer of crop-nutrient and animal-feed products fell short of Wall Street's expectations. BHP Billiton Ltd., up $1.26 at $50.88. A Prudential Equity Group LLC analyst raised his rating on the mining company, citing expectations for higher oil and uranium prices. Mylan Laboratories Inc., up 55 cents at $21.75. The drug maker raised its profit forecast because of strong sales of generic drugs. NASDAQ Autodesk Inc., up $1.22 at $40.06. A Goldman Sachs analyst raised his rating on the software developer, predicting a strong quarter and sizable growth. Adolor Corp., down $5.06 at $3.66. The biopharmaceutical company suspended clinical studies and withdrew an application for a constipation-relief drug.
Market Pulse Breaking News Alert for Tuesday, April 10, 2007: SGCP ...
ATLANTA, GA -- (MARKET WIRE) -- 04/10/07 -- Market Pulse News Alert for this AM, Stocks to Watch are: Sierra Gold Corporation (PINKSHEETS: SGCP), Dendreon Corp. (NASDAQ: DNDN), Cell Genesys Inc. (NASDAQ: CEGE) and Intel Corp. (NASDAQ: INTC). Investors need to be watching Sierra Gold Corporation (PINKSHEETS: SGCP) this AM! Sierra Gold is engaged in the exploration and development of gold and diamond properties in West Africa. Sierra Gold Corporation owns the mining rights of Northern Star Resources Ltd, a Sierra Leone incorporated gold and diamond mining company. The rights include a secured 40 sq/km prime mining concession located on the North Pampana River which is one of Sierra Leone's richest known alluvial gold mining rivers. The country became famous world-wide after the discovery of the Star of Sierra Leone, a magnificent 969 carat diamond.
West Aurora School District 129
Herget has been on the District 129 school board since 1999. She is a mother of two grown children. She is involved with the West Aurora Alumni Association and the Child Welfare Society of Aurora.What are your top priorities if elected?To continue to build and maintain trust between the community and board. With that in place, we can successfully implement our Vision 129, which was designed with the help of Dr. Rydland. The priorities outlined in that vision are: Improved student learning, which drives every decision we make; time, tools and training for teachers; safe, secure facilities; financial responsibility; and active community involvement. Those have been, and will remain my priorities if re-elected.What past decision made by this elected body did you most disagree with and why?During my tenure on the board, the decision that I disagreed with most was to move the construction of the "new" Greenman School from where it was originally planned (in the existing neighborhood) to a site on the far west side of Aurora.
Vanu and Globecomm Systems Team Up to Create a High Performance ...
CAMBRIDGE, Mass. $ HAUPPAUGE, N.Y., BUSINESS WIRE -- Vanu(R), Inc., the leading software radio innovator for the wireless infrastructure industry, and Globecomm Systems Inc. (NASDAQ: GCOM), a worldwide provider of end-to-end, cellular and satellite-based communications, today announced a joint solution designed to bring a turnkey, multi-standard wireless offering to rural wireless operators. The Vanu/Globecomm solution enables carriers to simultaneously support both GSM and CDMA from a hosted switch service so that operators don't have to invest in a Mobile Switching Center (MSC) nor will they have to replicate radio Microsoft Office Access 2003
RoyalDiscount-$169.95
Buy.com-$213.99
VioSoftware-$169.94
');" onMouseOut="hideAd();" class=Hotlink>access network (RAN) hardware for each new technology they add to their service offering.
Six Ways to Limit Uncle Sam's Take
Why are mutual funds such a potential tax headache? By law, mutual funds are required to pass all income and realized profits on investments along to shareholders through income and capital gains distributions. If you're investing through a taxable account, you'll have to pay taxes on those distributions. Short-term gains are taxed at the higher ordinary-income rate, as is income from taxable bonds, commodities, and real estate investment trusts. Meanwhile, long-term gains and stock dividends are generally taxed at the 15% rate. Thus, funds that trade a lot, and thus generate heavy short-term gains, generally aren't tax efficient. The same is true for income-heavy offerings, such as bond or REIT funds. That's not to say you shouldn't have fast-trading funds in your portfolio or that you should avoid bonds and REITs.
Adolor Shares Drop After Bowel-Treatment Test Halted (Update4)
April 10 (Bloomberg) -- Adolor Corp.'s shares lost more than half their value after the company put development of a bowel- disorder drug on hold because of increased rates of heart attacks, benign and malignant tumors, and bone fractures. The drug alvimopan, known as Entereg, was tested in patients whose bowels weren't properly functioning because they were taking painkillers, Adolor said. After a year, researchers found seven cases of heart attacks out of 538 patients on the drug, compared with zero out of 267 on a placebo, Adolor and its London-based partner, GlaxoSmithKline Plc, said yesterday. The findings dashed hopes of approval this year for Entereg, Adolor's leading product in development. U.S. regulators asked for more data on the drug's risks last year, leading the Exton, Pennsylvania, company to disband a sales force that had little prospect of anything to sell.
|
